Blood markers for muscle loss in kidney disease patients
Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study examines whether a simple blood test can help doctors measure muscle loss in people with end-stage kidney disease on dialysis. Understanding this connection may help improve treatment and overall health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have end-stage kidney disease and have been on hemodialysis (a blood-cleaning treatment) for more than 3 months
- You have not been hospitalized or had an active infection in the past 4 weeks
- You do not have active cancer or recent cancer treatments
- You do not have severe liver disease with complications
- You are able and willing to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at a simple blood test to see if it can help understand muscle loss in people with chronic lung disease. The goal is to find better ways to support muscle health.
This trial tests whether a drug called roxadustat can help treat muscle loss (sarcopenia) in people on hemodialysis. It aims to see if improving anemia also strengthens muscles.
This trial is for adults with chronic kidney disease and low muscle strength (sarcopenia). It aims to find ways to improve outcomes, especially if you have a higher risk of complications.
This study tests a special amino acid supplement to see if it can help improve muscle strength and function in people with advanced chronic kidney disease (CKD) who have low hand grip strength, often a sign of muscle loss. It may offer a way to preserve muscle health without dialysis.
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
This study looks at whether measuring certain proteins in your blood (myokines) can help detect muscle loss (sarcopenia) in people with liver cancer, and compares these blood tests to special CT scans. If you're newly diagnosed with liver cancer and have a CT scan already, you may be able to join.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.